Skip to main content
. 2020 Oct 19;34:2058738420966497. doi: 10.1177/2058738420966497

Figure 2.

Figure 2.

The frequencies of innate immune cells in COVID-19 and control subjects. The percentages of CD56low CD16+ NK cells, CD56high CD16+/− NK cells, and monocytes were studied by flow cytometry (a and b) and then analyzed (c–e). The results are representative of 57 independent experiments for COVID-19 patients at the first day of treatment, 51 independent experiments for COVID-19 patients in 10 days of treatment, and 40 independent experiments for healthy individuals. Each bar in (c–e) shows mean ± SEM.

*P < 0.05, **P < 0.01, ****P < 0.0001.